Variant report

Variant	nsv970724
Chromosome Location	chr6:28778144-28784760
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:21)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:28692413..28694711-chr6:28778373..28780345,2	K562	blood:
2	chr6:28778307..28780155-chr6:28804697..28807128,2	K562	blood:
3	chr6:28737526..28738316-chr6:28777463..28778342,2	K562	blood:
4	chr6:28777118..28779341-chr6:28889220..28890745,2	MCF-7	breast:
5	chr6:28722382..28725655-chr6:28783034..28786428,3	K562	blood:
6	chr6:28688964..28691307-chr6:28783200..28785150,2	K562	blood:
7	chr6:28774872..28779186-chr6:28780865..28786550,9	K562	blood:
8	chr6:27112538..27114831-chr6:28781719..28783622,2	K562	blood:
9	chr6:28771451..28773263-chr6:28777101..28779175,2	K562	blood:
10	chr6:28774872..28779186-chr6:28780865..28786550,9	K562	blood:
11	chr6:28722382..28724843-chr6:28784005..28786428,2	K562	blood:
12	chr6:28783316..28785641-chr6:28791797..28793442,2	K562	blood:
13	chr6:28187117..28189206-chr6:28783315..28785702,2	K562	blood:
14	chr6:28746343..28748629-chr6:28776362..28778668,2	K562	blood:
15	chr6:28779162..28781130-chr6:28862892..28865549,2	K562	blood:
16	chr6:28653637..28654159-chr6:28777644..28778612,2	MCF-7	breast:
17	chr6:28767356..28769263-chr6:28782865..28784537,2	K562	blood:
18	chr6:28768996..28771268-chr6:28774440..28778213,3	K562	blood:
19	chr6:28687938..28689790-chr6:28777726..28779382,2	K562	blood:
20	chr6:28723977..28727923-chr6:28779903..28783132,3	K562	blood:
21	chr6:28687325..28688855-chr6:28783516..28785419,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000225173	chromatin interactions
ENSG00000224157	chromatin interactions
ENSG00000197903	chromatin interactions
ENSG00000204713	chromatin interactions

Extended variants
information (count: 236 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:236 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562850156	chr6:28778195-28778196	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs76499981	chr6:28778204-28778205	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs550982035	chr6:28778304-28778305	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs540513647	chr6:28778317-28778318	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs181544104	chr6:28778328-28778329	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs147213783	chr6:28778383-28778384	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs140648084	chr6:28778411-28778412	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs116158701	chr6:28778417-28778418	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs169683	chr6:28778419-28778420	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs567961475	chr6:28778429-28778430	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs3131342	chr6:28778475-28778476	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs371508718	chr6:28778514-28778515	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs528563523	chr6:28778526-28778527	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs570789943	chr6:28778532-28778533	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs539768222	chr6:28778593-28778594	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs169682	chr6:28778614-28778615	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs576198334	chr6:28778706-28778707	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs3131341	chr6:28778723-28778724	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs571588997	chr6:28778730-28778731	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs376466841	chr6:28778756-28778757	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs185926789	chr6:28778835-28778836	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs149762340	chr6:28778847-28778848	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs562893134	chr6:28778902-28778903	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs200222944	chr6:28778908-28778909	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs112920264	chr6:28778911-28778912	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs142204688	chr6:28778918-28778919	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs386358867	chr6:28778922-28778923	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs116398972	chr6:28778923-28778924	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs531978777	chr6:28778949-28778950	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs547970693	chr6:28779012-28779013	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs191217610	chr6:28779127-28779128	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs182590387	chr6:28779137-28779138	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs186098979	chr6:28779166-28779167	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs570479588	chr6:28779183-28779184	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs373850245	chr6:28779277-28779278	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs554018979	chr6:28779333-28779334	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs565413955	chr6:28779335-28779336	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs573200700	chr6:28779342-28779343	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs539707208	chr6:28779344-28779345	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs550056023	chr6:28779348-28779349	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs528205362	chr6:28779369-28779370	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs535671338	chr6:28779392-28779393	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs554753100	chr6:28779407-28779408	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs417919	chr6:28779423-28779424	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs534050636	chr6:28779436-28779437	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs553704286	chr6:28779448-28779449	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs371142646	chr6:28779512-28779513	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs576837078	chr6:28779513-28779514	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs546170973	chr6:28779564-28779565	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs563242565	chr6:28779576-28779577	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:423 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:28775200-28778200	Weak transcription	Right Atrium	heart
2	chr6:28775600-28778600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
3	chr6:28775600-28778600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
4	chr6:28776800-28779200	Weak transcription	Hela-S3	cervix
5	chr6:28777000-28778600	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
6	chr6:28777000-28779000	Active TSS	A549	lung
7	chr6:28777200-28778400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
8	chr6:28777400-28778400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
9	chr6:28777400-28778600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
10	chr6:28777400-28778600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
11	chr6:28777600-28778200	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr6:28777600-28778200	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
13	chr6:28777600-28778200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr6:28777600-28778400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
15	chr6:28777600-28778400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
16	chr6:28777600-28778600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr6:28777600-28778600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
18	chr6:28777600-28778800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
19	chr6:28777600-28778800	Bivalent Enhancer	Fetal Muscle Leg	muscle
20	chr6:28777600-28779400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr6:28777800-28778200	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr6:28777800-28778200	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr6:28777800-28778200	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr6:28777800-28778200	Bivalent/Poised TSS	Muscle Satellite Cultured Cells	--
25	chr6:28777800-28778200	Bivalent/Poised TSS	HSMM	muscle
26	chr6:28777800-28778400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
27	chr6:28777800-28778400	Flanking Bivalent TSS/Enh	NH-A	brain
28	chr6:28777800-28778600	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
29	chr6:28777800-28778600	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
30	chr6:28777800-28778600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
31	chr6:28777800-28778600	Bivalent/Poised TSS	NHLF	lung
32	chr6:28777800-28778800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
33	chr6:28777800-28778800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr6:28777800-28778800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr6:28777800-28778800	Flanking Bivalent TSS/Enh	HepG2	liver
36	chr6:28777800-28778800	Bivalent/Poised TSS	HSMMtube	muscle
37	chr6:28777800-28778800	Flanking Bivalent TSS/Enh	NHEK	skin
38	chr6:28777800-28778800	Flanking Bivalent TSS/Enh	Osteobl	bone
39	chr6:28777800-28779000	Flanking Active TSS	HMEC	breast
40	chr6:28778000-28778200	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr6:28778000-28778200	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr6:28778000-28778200	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
43	chr6:28778000-28778200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr6:28778000-28778200	Bivalent Enhancer	Left Ventricle	heart
45	chr6:28778000-28778200	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
46	chr6:28778000-28778200	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
47	chr6:28778000-28778200	Flanking Bivalent TSS/Enh	GM12878-XiMat	blood
48	chr6:28778000-28778400	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
49	chr6:28778000-28778400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
50	chr6:28778000-28778400	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links